Literature DB >> 26884950

Correlation between PON1 gene polymorphisms and breast cancer risk: a Meta-analysis.

Yayuan Wen1, Zemin Huang2, Xiaohua Zhang1, Bo Gao1, Yujun He1.   

Abstract

OBJECTIVE: A number of studies have investigated the relationship between the PON1 gene polymorphisms and breast cancer risk, but the conclusions are not consistent. In this paper, a meta-analysis was conducted to explore the possible reasons for these inconsistencies, expecting to further clarify the correlation between PON1 gene polymorphisms and breast cancer risk.
METHODS: After searches in the database such as MEDLINE, EBSCO, ProQuest, Google Scholar, High-Wire, SID (Scientific Information Database) and PubMed, 7 literatures were collected. RevMan 5.2 software was used to perform the meta-analysis. Random-effects or fixed-effects model was used to analyze the odds ratio (OR) and 95% confidence intervals.
RESULTS: The analysis of L55M single nucleotide polymorphisms (SNPs) showed that M allele frequency was positively correlated with the incidence risk of breast cancer (OR=1.34, 95% CI: 1.03-1.74). While we did not found Q192R polymorphism associated with the risk of breast cancer (OR=1.0, 95% CI: 0.71-1.42).
CONCLUSION: For PON1 gene, the frequencies of M allele were associated with the incidence risk of breast cancer.

Entities:  

Keywords:  Paraoxonase; genetics; meta-analysis

Year:  2015        PMID: 26884950      PMCID: PMC4723795     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  14 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

Review 2.  Paraoxonase activity as a marker of exposure to xenobiotics in tobacco smoke.

Authors:  Halina Milnerowicz; Katarzyna Kowalska; Ewelina Socha
Journal:  Int J Toxicol       Date:  2015-05-07       Impact factor: 2.032

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.

Authors:  Victoria L Stevens; Carmen Rodriguez; Alexandre L Pavluck; Michael J Thun; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

5.  Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis.

Authors:  Mostafa Saadat
Journal:  Cancer Epidemiol       Date:  2011-11-30       Impact factor: 2.984

Review 6.  The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.

Authors:  L G Costa; W F Li; R J Richter; D M Shih; A Lusis; C E Furlong
Journal:  Chem Biol Interact       Date:  1999-05-14       Impact factor: 5.192

7.  The molecular basis of the human serum paraoxonase activity polymorphism.

Authors:  R Humbert; D A Adler; C M Disteche; C Hassett; C J Omiecinski; C E Furlong
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

8.  Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease.

Authors:  Lisa Gallicchio; Meghan A McSorley; Craig J Newschaffer; Han-Yao Huang; Lucy W Thuita; Sandra C Hoffman; Kathy J Helzlsouer
Journal:  Cancer Detect Prev       Date:  2007-04-10

9.  Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study.

Authors:  Lisa A Deroo; Sophia C E Bolick; Zongli Xu; David M Umbach; David Shore; Clarice R Weinberg; Dale P Sandler; Jack A Taylor
Journal:  Carcinogenesis       Date:  2013-10-15       Impact factor: 4.944

10.  CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.

Authors:  Cinzia Antognelli; Chiara Del Buono; Vienna Ludovini; Stefania Gori; Vincenzo N Talesa; Lucio Crinò; Francesco Barberini; Antonio Rulli
Journal:  BMC Cancer       Date:  2009-04-20       Impact factor: 4.430

View more
  4 in total

1.  M2PP: a novel computational model for predicting drug-targeted pathogenic proteins.

Authors:  Shiming Wang; Jie Li; Yadong Wang
Journal:  BMC Bioinformatics       Date:  2022-01-04       Impact factor: 3.169

2.  Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients.

Authors:  Meritxell Arenas; Anabel García-Heredia; Noemí Cabré; Fedra Luciano-Mateo; Anna Hernández-Aguilera; Sebastià Sabater; Marta Bonet; Marina Gascón; Salvador Fernández-Arroyo; Isabel Fort-Gallifa; Jordi Camps; Jorge Joven
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

3.  Paraoxonase 1 gene polymorphisms are associated with an increased risk of breast cancer in a population of Chinese women.

Authors:  Junrong Wu; Min Fang; Xiaoping Zhou; Bo Zhu; Zhi Yang
Journal:  Oncotarget       Date:  2017-04-11

4.  Association of Serum Paraoxonase 1 Activities, Polymorphisms and Oxidative Stress in Breast Cancer Patients with Type 2 Diabetes Mellitus.

Authors:  Fatma Ceyla Eraldemir; Nihal Üren; Tuğba Kum; Burcu Erbay; Deniz Şahin; Emel Ergül; Esra Acar; Doğa Özsoy; Mustafa Çekmen; Hale Kır; Zafer Utkan
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.